(PharmaNewsWire.Com, July 20, 2017 ) The market is showing evident potential in the given forecasting period. It is predicted to show significant growth in upcoming years as a result of the people being habitual of indulging in improper eating habits and thus facing stomach problems. The number of cases of these people falling sick has been rising significantly lately.
Antacid are chemical compounds used to neutralize excess acids in stomach, which helps in relieving stomach upset, heartburn and indigestion. In case of excessive secretion of acids in the digestive system, the natural mucous barrier responsible for protecting the lining in the stomach can damage the oesophagus. Increasing stomach problems case among people has led to pharmaceutical companies gaining interest in the Antacids market recently.
Antacids directly target the excess acids and get rid of them unlike other medications which only reduce or prevent stomach acid excretion. Thus, it shows better results compared to other medications. Further, Antacid come either as a liquid, chewable gum, or a tablet, hence being easy to use for patients across all age groups. These factors have been driving the growth of the Antacid market lately. Further, there are some challenges that are faced by antacids market as well, which include certain side effects like laxative effect, constipation, allergic reactions. Further people with certain health conditions are prone to adverse effects impacting their health conditions, like people with heart conditions may face problems due to high amount of sodium present in Antacids.
The Asia Pacific market for Antacid is segmented based on submarkets, applications and ingredients. By submarkets the market is further segmented under Chromatography, E-Clinical Trial Solutions, Wireless Health, Healthcare IT outsourcing, Clinical Trial Management Systems(CTMS), Immunoassay, Digital Pathology, Next Generation sequencing(NGS), Proteomics, Antacids with Antiflatulents. By Application the market is segment into Novel dietary fibers. Coming to ingredients the market is segmented under Protease, Modified starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & its substitutes. Under submarket segment, Chromatography accounted for the highest share in the market followed by Clinical Trial Management Systems (CTMS). Based on Ingredients segmentation, protease leads the market share. On the basis of geography, the Asia Pacific market is analysed under various countries namely China, India, Japan, Australia and South Korea.
The key market leaders for the Antacid market include WellSpring Pharm, GSK, First Aid Only, Private Lable, Procter & Gamble, Pfizer, Glaxosmithkline, Novaritis Consurmer Health, Boehringer Ingellheim Pharm, Johnson & Johnson.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
